OPEN END-TURBO-OPTIONSSCHEIN - RESMED | Market Closed - Bid/Ask 02:41:41 2024-06-11 pm EDT | After market 03:22:31 pm | |||
| 2.42 EUR | +4.31% |
|
2.335 | -3.51% |
| Current month | +22.75% | ||
| 1 month | -15.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-11 | 2.42 | +4.31% |
| 24-06-10 | 2.32 | -0.85% |
| 24-06-07 | 2.34 | +0.43% |
| 24-06-06 | 2.33 | -5.67% |
| 24-06-05 | 2.47 | +6.01% |
Delayed Quote Börse Stuttgart
Last update June 11, 2024 at 02:41 pm EDT
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | HSBC |
| WKN | HS697Y |
| ISIN | DE000HS697Y5 |
| Date issued | 2024-04-26 |
| Strike | 187.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.84 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.38 € |
|---|---|
| Lowest since issue | 1.76 € |
| Spread | 0.03 € |
| Spread % | 1.22% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
211.7
USD
Average target price
218.7
USD
Spread / Average Target
+3.34%
- Stock Market
- Certificates
- Certificat
